The announcement of a prostate cancer recurrence can be a shock, triggering discouragement, worry, and many questions. What do I do now? Which treatments might be effective for me?

The good news is that medicine has made tremendous progress. Treatments are now better tailored, more targeted, and often better tolerated. Their goal is to control the disease while preserving quality of life as much as possible.

In this article, you will learn about:

• The different types of recurrences and how they are detected;
• Common treatments used in cases of recurrence;
• New targeted therapies such as PSMA and PARP inhibitors;
• The limitations and considerations of treatments;
• How to move forward, ask the right questions, and participate in your own care.

Medical review by uro-oncologist Dr. Nawar Hanna, December 2025

Recurrence is not a step backward

After initial treatment, cancer can unfortunately return, sometimes as a localized recurrent disease. In such cases, it is detected early in a specific area, often with advanced imaging tools like PSMA PET scans.

There are two main types of recurrence:

• Localized: Occurring in or around the prostate. Targeted treatments may be possible to prevent wider and faster disease progression.
• Metastatic: When cancer spreads to other organs, especially bones or distant organs.

Standard treatments for recurrence

Salvage radiotherapy

When radiotherapy was not given during the first treatment, this option can be very effective for localized recurrence. It targets residual cancer cells while minimizing side effects. Often used after prostatectomy, it can delay the need for more intensive treatments such as hormone therapy.

Salvage radiotherapy can slow disease progression and, in some cases, achieve durable remission.

Hormone therapy

Hormone therapy remains a cornerstone for treating recurrent or advanced prostate cancer.

• Standard hormone therapy: intermittent or continuous, aiming to block testosterone production, which is essential for cancer cell growth.
• Newer-generation hormone therapies: more effectively block tumor cells’ access to androgens, prolong survival, and maintain a better quality of life.

Depending on your situation, your doctor may recommend continuous hormone suppression or treatment breaks to limit side effects and preserve overall well-being.

Chemotherapy

When the disease progresses despite hormone therapy, chemotherapy can reduce symptoms related to metastases and slow tumor growth. While side effects may occur, it is often better tolerated than expected and can improve both survival and quality of life.

Targeted therapies for recurrence

Radioligand therapy

Targeted therapies such as Lutetium-177 PSMA show promise for treating metastatic cancers resistant to conventional therapies. This treatment works like a guided missile, binding to PSMA-expressing cancer cells and destroying them with targeted radiation.

Advantages:

• More selective, reducing harm to healthy tissues and increasing the chance of slowing the disease;
• Less fatigue, fewer complications, and better treatment tolerance.

Considerations:

• May affect salivary glands and kidneys;
• Requires proper hydration and close monitoring.

PARP inhibitors

For patients with certain genetic mutations, PARP inhibitors offer a new therapeutic alternative. These drugs target cancer cells by exploiting defects in DNA repair, destroying them while sparing healthy cells.

This personalized treatment is a major advance in prostate cancer care, slowing disease progression by exploiting weaknesses in cancer cell DNA repair mechanisms.

Advantages:

• Personalized and effective approach;
• Improves quality of life;
• Delays disease progression.

Considerations:

• Significant fatigue;
• Digestive issues;
• Risk of anemia requiring close monitoring.

Limitations of targeted treatments

Even though these treatments bring hope, they have some limitations:

• Accessibility: PSMA-targeted therapy is covered by RAMQ and several provinces, but not all provincial programs.
• PARP inhibitors are increasingly accessible due to expanded genetic testing, but availability is still gradual. Discuss with your medical team about access options.
• Regular monitoring: Blood tests, imaging, and close medical follow-up are required to optimize outcomes and ensure appropriate care.

Research continues to improve these treatments to maximize benefits and reduce drawbacks. Your medical team is there to support you, answer your questions, and offer the best options for your situation.

Moving forward informed and supported

Facing a prostate cancer recurrence is never easy. But today, options are increasingly numerous, precise, and often better tolerated than before.

Understanding your options allows you to actively participate in your care. Your medical team is there to guide you at every step and help you make the choices that best support your well-being and future.

Next steps:

• Discuss potential treatments with your medical team;
• Always ask questions about side effects, follow-up, or daily life impact;
• If genetic testing is recommended, it could open access to new therapies;
• Stay informed about options that may become available in Quebec and in Canada.

At PROCURE, we believe that better understanding leads to better living with the disease. Our professionals are here to support you and answer your questions, seven days a week. Contact us at 1-855-899-2873 or visit our website procure.ca